Docstoc

XYLITOL CANADA RECEIVES TSX VENTURE EXCHANGE

Document Sample
XYLITOL CANADA RECEIVES TSX VENTURE EXCHANGE Powered By Docstoc
					  XYLITOL CANADA RECEIVES TSX VENTURE EXCHANGE APPROVAL
               FOR WARRANT TERM EXTENSION

March 20, 2012 – Toronto, Ontario – Xylitol Canada Inc. (“Xylitol Canada”, or the
“Company”) (XYL-TSX Venture) today announced that, further to its news release of
March 14, 2012, the TSX Venture Exchange has approved its application to extend the
term of 9,020,000 Xylitol Canada warrants (the “Warrants”), which were set to expire
on April 22, 2012, by one year. The Warrants were issued as part of a private placement
completed by Xylitol Canada in April, 2010. Each Warrant is exercisable into one
common share of Xylitol Canada at $0.40 per share.

As a result of the extension of the term of the Warrants, their new expiry date is April 22,
2013. All other terms of the Warrants will remain the same.

About Xylitol Canada Inc.

Xylitol Canada markets xylitol and xylitol based-products and is focused on becoming a
major low-cost manufacturer of xylitol and related products, serving the global market
from operations in North America.

Xylitol Canada’s business strategy is to leverage novel proprietary technology and
processes to become North America’s premier manufacturer of low cost, high quality
xylitol from readily available environmentally-sustainable biomass. Xylitol is an all-
natural sweetener which is marketed globally including Canada and the United States and
is accepted by the American Food and Drug Administration, the World Health
Organization and the American Dental Association. Xylitol contains 75% less
carbohydrates and 40% less calories than sugar, has a myriad of oral health benefits
including the prevention of tooth decay and is safe for diabetics. To date, wider spread
use of xylitol has been limited by the lack of a reliable, low cost, high quality supplier.

For further information about the Company, please contact Andrew Reid, President and
CEO, at (416) 288-1019, or by email at areid@xylitolcanada.com.

Neither TSX Venture Exchange Inc. nor its Regulation Services Provider (as that term is
defined in the policies of the TSX Venture Exchange) accepts responsibility for the
adequacy or accuracy of this release.

				
DOCUMENT INFO
Shared By:
Categories:
Tags:
Stats:
views:1
posted:3/30/2013
language:Latin
pages:1